Introduction
Axillary lymph node biopsy is a procedure performed to obtain tissue samples from lymph nodes located in the axilla, commonly known as the armpit. The axillary region contains a rich network of lymph nodes that serve as the primary drainage basin for the breast, upper limb, and lateral chest wall. When these nodes become enlarged or develop suspicious characteristics on imaging, tissue sampling is essential to establish a definitive diagnosis. Performed under real-time imaging guidance, axillary lymph node biopsy is a minimally invasive, highly accurate procedure that plays a central role in the staging and management of breast cancer, lymphoma, and other malignancies that involve the axillary nodal basin. It has largely replaced the need for surgical nodal excision in most diagnostic settings, offering patients a faster and safer route to diagnosis.
Anatomy of the Axillary Lymph Nodes
The axilla houses between twenty and forty lymph nodes arranged in several anatomical groups, including the anterior or pectoral nodes, posterior or subscapular nodes, lateral nodes along the axillary vein, central nodes, and apical nodes at the apex of the axilla. These nodes receive lymphatic drainage from the entire breast, the skin and soft tissues of the upper limb, and the lateral thoracic wall. In breast cancer, the axillary lymph nodes are the most common site of regional metastatic spread, and their involvement has critical implications for staging, prognosis, and treatment planning. The superficial location of axillary nodes makes them particularly well suited to imaging-guided percutaneous biopsy, as they are readily accessible and easily visualized.
Indications for the Procedure
Axillary lymph node biopsy is most frequently performed in the context of breast cancer diagnosis and staging. When a patient presents with a new breast cancer diagnosis and imaging reveals suspicious axillary lymphadenopathy, biopsy of the abnormal node is performed to determine whether regional nodal metastasis is present. This information directly influences the surgical approach, the sequencing of systemic therapy, and the extent of axillary surgery required. The procedure is also indicated in patients with unexplained axillary lymphadenopathy where lymphoma is suspected, in cases of metastatic malignancy from an unknown primary, in the evaluation of melanoma involving the upper limb or chest wall with axillary nodal involvement, and in the workup of infectious or inflammatory conditions causing axillary lymphadenopathy. Additionally, axillary node biopsy may be performed to assess treatment response following neoadjuvant chemotherapy in breast cancer patients, where nodal status after treatment influences decisions about further surgery.
Pre-Procedure Preparation
Before the procedure, the interventional radiologist reviews all available imaging including diagnostic ultrasound, mammography, MRI, and CT or PET-CT where applicable, to identify the most suspicious lymph node and plan the safest access route. The target node is selected based on imaging characteristics that suggest malignant involvement, such as loss of the normal fatty hilum, cortical thickening greater than three millimeters, a rounded rather than oval shape, and abnormal vascularity on Doppler assessment. Blood tests including a coagulation profile and full blood count are checked, and any anticoagulant medications are reviewed. The patient is counseled about the purpose and technique of the procedure, and written informed consent is obtained. No fasting is required for axillary biopsy in most cases, as the procedure is performed under local anesthetic only.
How the Procedure is Performed
The patient is positioned on the procedure table in the supine position with the ipsilateral arm abducted and the hand placed behind the head, which opens the axillary fossa and optimally exposes the lymph nodes for access. The axillary skin is cleaned with antiseptic solution and sterile drapes are applied. A real-time imaging assessment of the axilla is performed to confirm the location of the target node, assess its relationship to the axillary vessels, and select the optimal needle entry point and trajectory.
Local anesthetic is administered to the skin and subcutaneous tissues at the planned puncture site. The needle approach is carefully planned to avoid the axillary artery, axillary vein, and the brachial plexus, all of which lie in close proximity to the axillary lymph nodes. The trajectory is typically directed along the long axis of the node or from an inferior approach, keeping the needle path away from neurovascular structures at all times.
A core biopsy needle is advanced under continuous real-time imaging guidance through the skin and into the target lymph node. The automated biopsy device is fired to obtain a cylindrical tissue core. The needle is repositioned slightly and the process is repeated to collect multiple cores, usually two to four in total, ensuring adequate tissue for the full range of laboratory analyses. Specimens are submitted for routine histopathology, immunohistochemistry including hormone receptor and HER2 status in the context of breast cancer, and any additional molecular or flow cytometry studies required. Clip placement within the biopsied node is performed in many breast cancer centers at the time of biopsy, using a small metallic marker deployed through the coaxial needle. This clip marks the sampled node for future identification, particularly in patients who will undergo neoadjuvant chemotherapy before surgery, allowing the surgeon to locate and remove the specific node that was biopsy-proven at baseline. After sampling, the needle is withdrawn and pressure is applied to the puncture site to achieve hemostasis.
Post-Procedure Care and Recovery
Following the biopsy, the patient is observed briefly to confirm there are no immediate complications. Most patients are discharged within thirty to sixty minutes of the procedure. Mild soreness and bruising in the axilla are expected and typically resolve within a few days. Patients are advised to avoid heavy lifting or vigorous use of the arm for twenty-four hours and to keep the puncture site clean and dry. They are instructed to contact their clinical team if they develop worsening pain, significant swelling, numbness or tingling in the arm, or signs of infection. Pathology results are generally available within two to five working days.
Risks and Complications
Axillary lymph node biopsy is a safe procedure with a low complication rate when performed under imaging guidance by an experienced operator. Minor complications include local bruising, hematoma formation, and mild procedural discomfort. Serious complications are rare and include significant hemorrhage from injury to the axillary vessels, infection, and inadvertent injury to the brachial plexus causing temporary or, very rarely, persistent neurological symptoms. Meticulous real-time guidance, careful pre-procedure vascular mapping with Doppler imaging, and precise needle control minimize these risks substantially.
Diagnostic Value and Clinical Impact
The diagnostic accuracy of imaging-guided core needle biopsy of axillary lymph nodes is consistently high, exceeding ninety percent in most published series. In breast cancer management, accurate axillary nodal staging through percutaneous biopsy has transformed the surgical approach to the axilla. Patients with biopsy-confirmed nodal metastasis can proceed directly to axillary lymph node dissection or receive neoadjuvant chemotherapy before surgery, while those with negative nodes may be spared unnecessary axillary surgery altogether. The additional molecular information obtained from biopsied nodal tissue, including receptor profiling and genetic analysis, further enriches the diagnostic yield and supports precision treatment planning.
Conclusion
Axillary lymph node biopsy performed under imaging guidance is a precise, safe, and highly informative procedure that occupies a critical position in the diagnostic and staging workup of breast cancer, lymphoma, and other malignancies involving the axillary nodal basin. By delivering accurate histological and molecular information through a minimally invasive technique, it enables clinicians to make well-informed treatment decisions while sparing patients the morbidity of unnecessary surgical intervention. It remains one of the most impactful and frequently performed procedures in interventional radiology practice.